Han-Fei Ding

12PUBLICATIONS
30CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 28, 2026
Impaired Mevalonate-Dependent NAD⁺ Regeneration Suppresses Serine Biosynthesis and Enhances Sensitivity to PHGDH Inhibition.

|Aug 29, 2025
DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation.

Anamika Gupta, Mohit Bansal, Jane Ding

|Aug 26, 2025
Slc7a5 promotes T cell anti-tumor immunity through sustaining cytotoxic T lymphocyte effector function.

Chunwan Lu, Liyan Liang, Yanmin Wu

|Jun 04, 2025
HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism.

Hyeyoung Nam, Anirban Kundu, Suman Karki

|Sep 06, 2024
MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development.

Jane Ding, Mohit Bansal, Yuxia Cao

|Apr 14, 2023
Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma.

Gia-Buu Tran, Jane Ding, Bingwei Ye

Pageof 2

Frequent Collaborators

5 joint publications

Sunil Sudarshan

4 joint publications

Jane Ding

3 joint publications

Mohit Bansal

2 joint publications

Anamika Gupta